Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Costs of Hospital Admission on Primary Immunodeficiency Diseases.
Gholami K, Laali E, Abolhassani H, Ahmadvand A, Mohebbi N, Javadi MR, Aghamohammadi A, Rezaei N. Gholami K, et al. Among authors: mohebbi n. Iran J Public Health. 2017 Mar;46(3):342-350. Iran J Public Health. 2017. PMID: 28435820 Free PMC article.
Mycophenolic Acid pharmacokinetics early after kidney transplant.
Honarbakhsh N, Rouini MR, Lesan-Pezeshki M, Javadi MR, Karimzadeh I, Mohebbi N, Gholami K. Honarbakhsh N, et al. Among authors: mohebbi n. Exp Clin Transplant. 2013 Apr;11(2):112-7. doi: 10.6002/ect.2012.0094. Epub 2012 Nov 20. Exp Clin Transplant. 2013. PMID: 23176542 Free article.
Evaluating the Effects of Rivastigmine on Decision-Making in Patients with Mild Cognitive Impairment by Cambridge Neuropsychological Test Automated Battery (CANTAB); A Randomized, Double-Blind, Placebo-Controlled Trial.
Sadeghi S, Mohammadian F, Tehrani-Doost M, Gholami K, Mohebbi N. Sadeghi S, et al. Among authors: mohebbi n. Iran J Pharm Res. 2023 Oct 30;22(1):e138943. doi: 10.5812/ijpr-138943. eCollection 2023 Jan-Dec. Iran J Pharm Res. 2023. PMID: 38444714 Free PMC article.
Adverse Drug Reactions of Multiple Sclerosis Disease-modifying Drugs.
Salehbayat M, Abolfazli R, Mohebbi N, Savar SM, Shalviri G, Gholami K. Salehbayat M, et al. Among authors: mohebbi n. Basic Clin Neurosci. 2023 Nov-Dec;14(6):879-883. doi: 10.32598/bcn.2021.2848.2. Epub 2023 Nov 1. Basic Clin Neurosci. 2023. PMID: 39070198 Free PMC article.
Improving adverse drug event reporting by healthcare professionals.
Shalviri G, Mohebbi N, Mirbaha F, Majdzadeh R, Yazdizadeh B, Gholami K, Grobler L, Rose CJ, Chin WY. Shalviri G, et al. Among authors: mohebbi n. Cochrane Database Syst Rev. 2024 Oct 29;10(10):CD012594. doi: 10.1002/14651858.CD012594.pub2. Cochrane Database Syst Rev. 2024. PMID: 39470185 Free PMC article.
110 results